Clinical Trial Detail

NCT ID NCT01858883
Title Safety Study of INCB039110 in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements no
Sponsors Incyte Corporation
Indications

pancreatic adenocarcinoma

Advanced Solid Tumor

Therapies

Nab-paclitaxel

Filgrastim

Itacitinib

Gemcitabine

Age Groups: adult

No variant requirements are available.